What is the future of tocolysis?

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 117, Issue SUPPL., 2004, Pages

  Terrien, Jérémy ^a   Marque, Catherine ^a   Germain, Guy ^b  

^a UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

^b INRA Institut National de la Recherche Agronomique   (France)

Author keywords

Preterm labour; Tocolysis

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CYTOKINE; GELATINASE B; INTERLEUKIN 1BETA; NONSTEROID ANTIINFLAMMATORY AGENT; UTERUS SPASMOLYTIC AGENT;

CYTOKINE RELEASE; DNA MICROARRAY; DNA POLYMORPHISM; DOWN REGULATION; ELECTROMYOGRAPHY; GENE CONTROL; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; INSTRUMENTATION; PERINATAL PERIOD; PREMATURE LABOR; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SIDE EFFECT; UTERUS CONTRACTILITY;

EID: 7644244087     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2004.07.009     Document Type: Article

References (33)

1. G.N. Smith What are the realistic expectations of tocolytics? BJOG 110 Suppl 20 2003 103 106
2. S.L. West, B.P. Yawn, J.M. Thorp, M.J. Korhonen, D.A. Savitz, and H.A. Guess Tocolytic therapy for preterm labour: assessing its potential for reducing preterm delivery Paediatr. Perinat. Epidemiol. 15 2001 243 251
3. N.M. Fisk, and J. Chan The case for tocolysis in threatened preterm labour BJOG 110 Suppl. 20 2003 98 102
4. P.S. Ramsey, and D.J. Rouse Therapies administered to mothers at risk for preterm birth and neurodevelopmental outcome in their infants Clin. Perinatol. 29 2002 725 743
5. M. Ozkur, F. Dogulu, A. Ozkur, B. Gokmen, S.S. Inaloz, and A.S. Aynacioglu Association of the Gln27Glu polymorphism of the beta-2-adrenergic receptor with preterm labor Int. J. Gynaecol. Obstet. 77 2002 209 215
6. R. Landau, H.G. Xie, V. Dishy, C.M. Stein, A.J. Wood, and C.W. Emala Beta-2 adrenergic receptor genotype and preterm delivery Am. J. Obstet. Gynecol. 187 2002 1294 1298
7. P.E. Ferrand, S. Parry, M. Sammel, G.A. Macones, H. Kuivaniemi, and R. Romero A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans Mol. Hum. Reprod. 8 2002 494 501
8. T. Fujimoto, S. Parry, M. Urbanek, M. Sammel, G. Macones, and H. Kuivaniemi A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes J Biol Chem. 277 2002 6296 6302
9. M.R. Genc, S. Gerber, M. Nesin, and S.S. Witkin Polymorphism in the interleukin-1 gene complex and spontaneous preterm delivery Am. J. Obstet. Gynecol. 187 2002 157 163
10. P.T. Barton, S. Gerber, D.W. Skupski, and S.S. Witkin Interleukin-1 receptor antagonist gene polymorphism, vaginal interleukin-1 receptor antagonist concentrations, and vaginal Ureaplasma urealyticum colonization in pregnant women Infect. Immun. 71 2003 271 274
11. K. Aguan, J.A. Carvajal, L.P. Thompson, and C.P. Weiner Application of a functional genomics approach to identify differentially expressed genes in human myometrium during pregnancy and labour Mol. Hum. Reprod. 6 2000 1141 1145
12. E.C. Chan, S. Fraser, S. Yin, G. Yeo, K. Kwek, and R.J. Fairclough Human myometrial genes are differentially expressed in labor: a suppression subtractive hybridization study J. Clin. Endocrinol. Metab. 87 2002 2435 2441
13. G. Charpigny, M.J. Leroy, M. Breuiller-Fouche, Z. Tanfin, S. Mhaouty-Kodja, and P. Robin A functional genomic study to identify differential gene expression in the preterm and term human myometrium Biol. Reprod. 68 2003 2289 2296
14. K.W. Marvin, J.A. Keelan, R.L. Eykholt, T.A. Sato, and M.D. Mitchell Expression of angiogenic and neurotrophic factors in the human amnion and choriodecidua Am. J. Obstet. Gynecol. 187 2002 728 734
15. K.W. Marvin, J.A. Keelan, R.L. Eykholt, T.A. Sato, and M.D. Mitchell Use of cDNA arrays to generate differential expression profiles for inflammatory genes in human gestational membranes delivered at term and preterm Mol. Hum. Reprod. 8 2002 399 408
16. L.S. Tashima, S.Y. Yamamoto, M. Yasuda, L.K. Millar, and G.D. Bryant-Greenwood Decidual relaxins: gene and protein up-regulation in preterm premature rupture of the membranes by complementary DNA arrays and quantitative immunocytochemistry Am. J. Obstet. Gynecol. 187 2002 785 797
17. K.E. Bethin, Y. Nagai, R. Sladek, M. Asada, Y. Sadovsky, and T.J. Hudson Microarray analysis of uterine gene expression in mouse and human pregnancy Mol Endocrinol. 17 2003 1454 1469
18. B. Carbonne, V. Tsatsaris, V. Lejeune, and F. Goffinet Which tocolytics should be used in 2001? J. Gynecol. Obstet. Biol. Reprod. (Paris) 30 Suppl 1 2001 89 93
19. D. Devedeux, C. Marque, S. Mansour, G. Germain, and J. Duchene Uterine electromyography: a critical review Am. J. Obstet. Gynecol. 169 1993 1636 1653
20. I. Verdenik, M. Pajntar, and B. Leskosek Uterine electrical activity as predictor of preterm birth in women with preterm contractions Eur. J. Obstet. Gynecol. Reprod. Biol. 95 2001 149 153
21. S. Snowden, N.A. Simpson, and J.J. Walker A digital system for recording the electrical activity of the uterus Physiol. Meas. 22 2001 673 679
22. R.E. Garfield, H. Maul, W. Maner, C. Fittkow, G. Olson, and L. Shi Uterine electromyography and light-induced fluorescence in the management of term and preterm labor J. Soc. Gynecol. Investig. 9 2002 265 275
23. H. Eswaran, J.D. Wilson, P. Murphy, H. Preissl, and C.L. Lowery Application of wavelet transform to uterine electromyographic signals recorded using abdominal surface electrodes J. Matern. Fetal. Neonatal. Med. 11 2002 158 166
24. M. Khalil, and J. Duchene Uterine EMG analysis: a dynamic approach for change detection and classification IEEE Trans. Biomed. Eng. 47 2000 748 756
25. G. Kavsek, M. Pajntar, and B. Leskosek Electromyographic activity of the uterus above the placental implantation site Gynecol. Obstet. Invest. 48 1999 81 84
26. S.A. Price, and A.L. Bernal Uterine quiescence: the role of cyclic AMP Exp. Physiol. 86 2001 265 272
27. E.S. Park, C.O. Echetebu, S. Soloff, and M.S. Soloff Oxytocin stimulation of RGS2 mRNA expression in cultured human myometrial cells Am. J. Physiol. Endocrinol. Metab. 282 2002 580 584
28. S.D. Rybalkin, I.G. Rybalkina, R. Feil, F. Hofmann, and J.A. Beavo Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells J. Biol. Chem. 277 2002 3310 3317
29. W.P. Arend, and C.J. Guthridge Biological role of interleukin-1 receptor antagonist isoforms Ann. Rheum. Dis. 59 Suppl 1 2000 i60 i64
30. E. Tartour, R.S. Lee, and W.H. Fridman Anti-cytokines: promising tools for diagnosis and immunotherapy Biomed. Pharmacother. 48 1994 417 424
31. P. Barrera, L.A. Joosten, A.A. den Broeder, L.B. van de Putte, P.L. van Riel, and W.B. van den Berg Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin-1 and TNFalpha in patients with rheumatoid arthritis Ann. Rheum. Dis. 60 2001 660 669
32. J.S. Kruessel, H.Y. Huang, Y. Wen, A.R. Kloodt, P. Bielfeld, and M.L. Polan Different pattern of interleukin-1 beta-(IL-1 beta), interleukin-1 receptor antagonist- (IL-1ra) and interleukin-1 receptor type I- (IL-1R tI) mRNA-expression in single preimplantation mouse embryos at various developmental stages J. Reprod. Immunol. 34 1997 103 120
33. L. Padyukov, J. Lampa, M. Heimburger, S. Ernestam, T. Cederholm, and I. Lundkvist Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis Ann. Rheum. Dis. 62 2003 526 529